JESSICA SNOOK: Open Payments
NPI 1003883661 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,059 in 144 payments from 25 companies in 2025. Trend: 2023 $1,594 · 2024 $2,307 · 2025 $3,059
Food & beverage: $3,059
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $732 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $325 |
| Janssen Biotech, Inc. | 10 | $205 |
| Ardelyx, Inc. | 10 | $203 |
| QOL Medical, LLC | 9 | $198 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $170 |
| Regeneron Healthcare Solutions, Inc. | 7 | $160 |
| Ipsen Biopharmaceuticals, Inc | 7 | $143 |
| Celltrion USA Inc. | 6 | $130 |
| PFIZER INC. | 6 | $111 |
Products named: RINVOQ, ENTYVIO, SKYRIZI, TREMFYA, IBSRELA, Sucraid, XIFAXAN, DUPIXENT.
Industry payments across VA — which companies pay providers there.
